Ola Holmlund
CEO
CEO since 2018. Bachelor’s degree in business administration.
Born: 1969
Experience: Ola has more than 20 years of experience in international sales and launch of medical technology, pharmaceuticals and other life science products.
Ongoing assignments: –
Previous assignments in the last five years: –
Owns more than five percent of the shares in: –
Holdings in the Company: 3,370,000 shares and 750,000 warrants (TO 2).
Charlotta Ekman
Chief Financial Officer
Chief Financial Officer since 2022. Pol.mag and Master in Innovation and entrepreneurship.
Born: 1981
Experience: Charlotta has previous experience from a number of leading positions as CFO and COO at innovative and expansive companies.
Ongoing assignments: Board member of Addace Consulting AB.
Previous assignments in the last five years: CFO of Acosense AB.
Owns more than five percent of the shares in: Addace Consulting AB.
Holdings in the Company: 3,000,000 shares and 750,000 warrants (TO 2).
Jan Holmbäck
Chief Scientific Officer
Chief Scientific Officer since 2010. Doctoral degree in organic chemistry.
Born: 1957
Experience: Jan is a co-founder of Lipidor and has almost 40 years of experience in drug development, especially in analytical and organic chemistry.
Ongoing assignments: Chairman of the board of the Swedish Society for Nature Conservation in Vaxholm. CEO and board member of SumIT System Aktiebolag.
Previous assignments in the last five years: –
Owns more than five percent of the shares in: SumIT System AB and Lipidor AB.
Holdings in the Company: 3,858,811 shares and 750,000 warrants (TO 2).
Vibhu Rinwa
Chief Operating Officer
Vibhu Rinwa has a Doctoral degree in Pharmaceutical Sciences started working with Lipidor in 2018.
Born: 1986
Experience: Vibhu has been able to acquire a large amount of knowledge in formulation science and gained broad experience in pre-clinical and clinical development. She has worked on drug delivery in different complex dosage form designs for New Chemical Entities and value-added generics.
Ongoing assignments: –
Previous assignments in the last five years: –
Owns more than five percent of the shares in: –
Holdings in the Company: 1,035,755 shares and 250,000 warrants (TO 2).